To investigate safety and eficacy of yishumei--a injectable cross-linked sodium hyaluronate gel on alleviating moderate and severe nasolabial groove.
Methods A randomized,single-blind,parallel controlled study was conducted on selected volunteers with moderate and severe nasolabial groove.Restylane" ll or yishumei"(<1.5 ml)was injected either side to correct nasolabial groove.Bilateral nasolabial wrinkle severity rating scale (WSRS)and adverse events were evaluated by surgeon and volunteers independently at preoperative and immediately,4 weeks,12 weeks,24 weeks after procedure.SPSS13.0 software was used for statistical analysis.
Results The average age of 30 selected volunteers(28 female,2 male)was 45.8.Bilateral nasolabial WSRS declined after procedure,and the difference between
WSRS of immediately and of 24 weeks later has no statistically significance(P>0.05).Two cases of adverse events (2/30,6.67%)occurred during the test,and one case thought to be related to the research materials.
Reference From Journal of Practical Dermatology,Feb.2016 ,Vol.9,No.1
Writer:
ZHOU Zhi qiang,SUI Zhi fu,LIU Chang,et al
Institute of Skin Damage and Repair,GeneralHospital ofBeijing M ilitary Com mand,Beijing 100700,China
-
singclean | 2017-08-17
Singclean’s Medical Sodium Hyaluronate Gel for Bone Joint Gained EU MDR CE Certification, Ranking Among First 3 Globally! 协合医疗骨科医用透明质酸钠凝胶成功斩获欧盟MDR CE认证!跻身全球前三!This achievement sets multiple industry records: it is the first MDR CE certificate for hyaluronic acid-based orthopedic products ever issued by DNV worldwide. Singclean Medical has become the first Chinese company to obtain such certification in this category and has successfully ranked among the first 3 companies globally to secure a viscosupplementation MDR CE certificate. This accomplishment underscores Singclean Medical's technological expertise and international competitiveness in the field of orthopedic biomaterials and hyaluronic acid applications. 此次认证创造了多项行业纪录:这是DNV在全球范围内签发的首张透明质酸骨科类MDR CE证书;协合医疗为中国首家获此证书的企业,更成功跻身全球前三。这一成绩,充分彰显了协合医疗在骨科生物医用材料及透明质酸领域的技术积累与国际竞争力。 -
singclean | 2017-08-17
Singclean Medical’s 2nd International Aesthetic Medicine Leadership Summit Concludes Successfully in Shanghai Shanghai, August 27, 2026 – The 2nd International Aesthetic Medicine Leadership Summit, hosted by Singclean Medical, was held at W Shanghai – The Bund, within the IMCAS China Congress venue. Under the theme “Global Vision, Opening a New Chapter,” the summit served as a cross‑border, multi‑disciplinary platform for professional exchange, gathering an impressive lineup of leading physicians and global partners. -
singclean | 2017-08-17
Singclean Medical to Showcase Innovative Aesthetic and Medical Solutions at Dubai Derma 2026 and Medical Fair Asia 2026HANGZHOU, China – Hangzhou Singclean Medical Products Co., Ltd., a leading innovator in absorbable biomaterials and medical aesthetic solutions, has announced its participation in two major international exhibitions in September 2026: Dubai Derma 2026 in the United Arab Emirates and Medical Fair Asia 2026 in Singapore.